Th1 epitope repertoire on the α subunit of human muscle acetylcholine receptor in myasthenia gravis

Neurology

Volumn 48, Issue 6, 1997, Pages 1643-1653

  Wang, Zeng Yu ^a   Okita, David K ^a   Howard Jr , James ^b   Conti Fine, Bianca M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; EPITOPE; GAMMA INTERFERON; RECEPTOR SUBUNIT; SYNTHETIC PEPTIDE;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DEPLETION; MALE; MONONUCLEAR CELL; MYASTHENIA GRAVIS; PRIORITY JOURNAL;

EID: 0030749930     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.6.1643     Document Type: Article

References (67)

1. Lindstrom J, Shelton D, Fujii Y. Myasthenia gravis. Adv Immunol 1988;42:233-284.
2. Schonbeck S, Chrestel S, Hohlfeld R. Myasthenia gravis: Prototype of the antireceptor autoimmune diseases. Int Rev Neurobiol 1990;32:175-200.
3. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330: 1797-1810.
4. Conti-Tronconi BM, McLane KE, Raftery MA, Grando SA, Protti MP. The nicotinic acetylcholine receptor: Structure and autoimmune pathology. Crit Rev Biochem Mol Biol 1994;29: 69-123.
5. Nakano S, Engel AG. Myasthenia gravis: quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30 patients. Neurology 1993;43:1167-1172.
6. Vandenbark AA, Hashim G, Offner H. TCR peptide therapy in autoimmune diseases. Int Rev Immunol 1993;2:251-277.
7. Sette A, Alexander J, Ruppert J, et al. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu Rev Immunol 1994;12:413-431.
8. Chicz RM, Urban RG. Analysis of MHC-presented peptides: applications in autoimmunity and vaccine development. Immunol Today 1994;15:155-160.
9. Lament A. Are we closer to selective immunotherapy for autoimmune diseases? Immunol Today 1994;15:45-47.
10. Protti MP, Manfredi AA, Horton RM, Bellone M, Conti-Tronconi BM. Myasthenia gravis: recognition of a human autoantigen at the molecular level. Immunol Today 1993;14: 363-368.
11. Sun J-B, Harcourt G, Wang Z-Y, et al. T cell responses to human recombinant acetylcholine receptor a subunit in myasthenia gravis and controls. Eur J Immunol 1992;22:1553-1559.
12. + T epitope repertoire on the human acetylcholine receptor α subunit in severe myasthenia gravis. A study with synthetic peptides. Neurology 1992;42:1092-1100.
13. Manfredi AA, Protti MP, Dalton MWM, Howard JF Jr, Conti-Tronconi BM. Myasthenia Gravis: T helper repertoire on the γ and δ subunits of human muscle acetylcholine receptor. J Clin Invest 1993;92:1055-1067.
14. + T lines propagated with tetanus toxoid or with synthetic tetanus toxoid sequences. J Autoimmun 1996;9:79-88.
15. Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansion in normal and clinical samples. Immunol Today 1995;16:176-181.
16. Sercarz E, Lehmann PV, Ametani A, et al. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993;11:729-766.
17. Newsom-Davis J, Harcourt G, Sommer N, et al. T reactivity in myasthenia gravis. J Autoimmun 1989;2(suppl):101-108.
18. Romagnani S. Biology of Th1 and Th2 cells. J Clin Immunol 1995;15:121-129.
19. Olsson T. Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurology 1995;45(suppl 6):11-15.
20. + cells of myasthenia gravis patients and healthy subjects. J Clin Invest 1994;93:1020-1028.
21. Yi Q, Ahlberg R, Pirskanen R, et al. Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells. J Neuroimmunol 1994;50:177-186.
22. Link J, Soderstrom M, Ljungdahl A, Lefvert AK. Organspecific autoantigens induce interferon-γ and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Neurology 1994;44:728-734.
23. Schoepfer R, Luther M, Lindstrom J. The human medulloblastoma cell line TE671 expresses a muscle-like acetylcholine receptor. Cloning of the α-subunit cDNA. FEBS Lett 1988; 226:235-240.
24. Houghten RA. General method for the rapid solid phase synthesis of large numbers of peptides: specificity of antigenantibody interaction at the level of individual amino acids. Proc Natl Acad Sci USA 1985;82:5131-5135.
25. Rudensky AY, Preston-Hurburt P, Hong SC, Barlow A, Jane-way CA Jr. Sequence analysis of peptides bound to MHC class II molecules. Nature 1991;353:622-627.
26. d. Science 1992;256:1817-1820.
27. Stern LJ, Brown JH, Jardetzky TS. et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994;368:215-221.
28. Protti MP, Manfredi AA, Straub C, Howard JF Jr, Conti-Tronconi BM. Immunodominant regions for T helper sensitization on the human nicotinic receptor α subunit in myasthenia gravis. Proc Natl Acad Sci USA 1990;87:7792-7796.
29. + T cell response to the human acetylcholine receptor α subunit in myasthenia gravis. A study with synthetic peptides. J Immunol 1990;144:1276-1281.
30. Czerkinsky CC, Anderson G, Ekre H-P, Nilsson L-Å, Klareskog L, Ouchterlony O. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Immunol Methods 1988;110:29-36.
31. Link H, Olsson O, Sun J-B, et al. Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls. J Clin Invest 1991;87:2191-2196.
32. Wang Z-Y, Link H, Huang W-X. T cell immunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis. Scand J Immunol 1993;37:615-622.
33. Kabilan L, Anderson G, Lolli F, Ekre H-P, Olsson T, Troye-Blomberg M. Detection of intracellular expression and secretion of interferon-γ at the single-cell level after activation of human T cells with tetanus toxoid in vitro. Eur J Immunol 1991;20:1085-1089.
34. Sun J-B, Olsson T, Wang W-Z, et al. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol 1991;21:1461-1468.
35. Yi Q, Lefvert AK. Idiotype- and anti-idiotype-reactive T lymphocytes in myasthenia gravis: Evidence for the involvement of different surpopulations of T helper lymphocytes. J Immunol 1994;153:3353-3359.
36. + cells in Myasthenia Gravis patients and in healthy controls. J Immunol 1995;154:1508-1520.
37. Protti MP, Manfredi AA, Wu XD, Moiola L, Howard JF Jr, Conti-Tronconi BM. Myasthenia Gravis: T epitopes of the δ subunit of human muscle acetylcholine receptor. J Immunol 1991;146:2253-2261.
38. Oldstone MBA. Molecular mimicry and autoimmune disease. Cell 1987;50:819-820.
39. Lehman PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;358:155-157.
40. Miller SD, McRae BL, Vanderlugt CL, et al. Evolution of the T-cell repertoire during the course of experimental immunemediated demylinating diseases. Immunol Rev 1995;144:225-244.
41. + T cells on diphtheria toxin: structural features of sequence segments forming epitopes recognized by most subjects. Eur J Immunol 1995;25:3207-3214.
42. Panina-Bordignon P, Tan A, Termijtelen A, Demotz S, Corradin G, Lanzavecchia A. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol 1989;19: 2237-2242.
43. + T cells on tetanus toxoid: identification of immunodominant sequence segments. J. Infectious Diseases 1997;175:382-391.
44. O'Sullivan D, Arrhenius T, Sidney J, et al. On the interaction of promiscous antigenic peptides with different DR alleles. J Immunol 1991;147:2663-2669.
45. Manfredi AA, Yuen M-H, Moiola L, Protti MP, Conti-Tronconi BM. Human acetylcholine receptor presentation in Myasthenia Gravis: DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules. J Immunol 1994;152:4165-4174.
46. Yuen M-H, Macklin K, Conti-Fine BM. MHC class II presentation of human acetylcholine receptor in Myasthenia Gravis: Binding of synthetic gamma subunit sequences to purified DR molecules. J Autoimmun 1996;9:67-77.
47. Choe S, Bennett MJ, Fujii G, et al. The crystal structure of diphtheria toxin. Nature 1992;357:216-222.
48. Barkas T, Gabriel J-M, Mauron A, et al. Monoclonal antibodies to the main immunogenic region of the nicotinic acetylcholine receptor bind to residues 61-76 of the a subunit. J Biol Chem 1988;263:5916-5920.
49. Tzartos SJ, Kokla A, Walgrave SL, Conti-Tronconi BM. Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the α subunit. Proc Natl Acad Sci USA 1988;85:2899-2903.
50. Bellone M, Tang F, Milius R, Conti-Tronconi BM. The main immunogenic region of the nicotinic acetylcholine receptor. Identification of amino acid residues interacting with different antibodies. J Immunol 1989;143:3568-3579.
51. Conti-Fine BM, McLane KE, Lei S. Antibodies as tools to study the structure of membrane proteins. The case of the nicotinic acetylcholine receptor. Annu Rev Biophys Biomol Struct 1996;25:197-229.
52. Hohlfeld R, Toyka KY, Miner LL, Walgrave SL, Conti-Tronconi BM. Amphipathic segment of the nicotinic receptor α subunit contains epitopes recognized by T lymphocytes in myasthenia gravis. J Clin Invest 1988;81:657-660.
53. Melms A, Malcherek G, Gern U, et al. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the α-subunit. Ann Neurol 1992;31:311-318.
54. Harcourt G, Sommer N, Rothbard J, Willcox HNA, NewsomDavis J. A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis. J Clin Invest 1988;82:1295-1300.
55. Brocke S, Brautbar C, Steinman L, et al. In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and related to HLA class II genes. J Clin Invest 1989;82: 1894-1900.
56. Oshima M, Ashizawa T, Pollack MS, Atassi MZ. Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the δ subunit. Eur J Immunol 1990;20:2563-2569.
57. Lombardi G, Sidhu S, Batcher R, Lechler R. Anergic T cells as suppressor cells in vitro. Science 1994;264:1587-1589.
58. Gammon G, Sercarz EE. How some T cells escape tolerance induction. Nature 1989;342:183-185.
59. Gammon G, Sercarz EE. Does the presence of self-reactive T cells indicate the breakdown of tolerance? Clin Immunol Immunopathol 1990;56:287-297.
60. Mondino A, Jenkins MJ. Surface protein involved in T cell costimulation. J Leukoc Biol 1994;55:805-815.
61. Zhang Y, Frutiger S, Hughes GJ, Savoy M-C, Barkas T. Identification of T cell epitopes of autoantigens using recombinant proteins; studies on experimental autoimmune myasthenia gravis. Immunology 1990;71:538-543.
62. Brod SA, Benjamin D, Hafler DA. Restricted T cell expression of IL-2/IFN-γ mRNA in human inflammatory disease. J Immunol 1991;147:810-815.
63. Voskuhl RR, Martin R, Bergman C, et al. T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 1993;15:137-143.
64. Van der Veen RC, Kapp JA, Trotter JL. Fine specificity differences in the recognition of an encephalitogenic peptide by T helper 1 and 2 cells. J Neuroimmunol 1993;48:221-226.
65. Correal J, Gilmore W, MaMillan M, et al. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J Immunol 1995;154:2959-2968.
66. Wang Z-Y, Link H, Lungdahl A, et al. Induction of interferon-γ, interleukin-4 and transforming factor-β in rats orally tolerized against experimental autoimmune myasthenia gravis. Cell Immunol 1994;157:353-368.
67. Gu D, Wogensen L, Calcutt NA, et al. Myasthenia gravis-like syndrome induced by expression of interferon-γ in the neuromuscular junction. J Exp Med 1995;181:547-557.